The Foundation Role of IV Iron Repletion for the Patient with Hematologic Disorders and Oncologic Malignancies Associated with IDA: What Have The Clinical Trials Taught Us? Where Does the Evidence Lead Us?

The Foundation Role of IV Iron Repletion for the Patient with Hematologic Disorders and Oncologic Malignancies Associated with IDA: What Have The Clinical Trials Taught Us? Where Does the Evidence Lead Us?


Published

December 15, 2016

Created by

CMEducation Resources symposium

Related Presenters

George Rodgers III, MD, PhD

George Rodgers III, MD, PhD

Professor, Division of Hematology and Hematologic Malignancies at Huntsman Cancer Institute